NCT05282134

Brief Summary

The aim of this study is to evaluate the effects of wet cupping therapy (WCT) on migraine patients and compare it with acupuncture. The patients will be randomized into three groups. WCT will be applied once a month to patients in group 1 and acupuncture will be applied to group 2, while the control group (group 3) will be on standard therapy for migraine. An evaluation will be made before treatment and at the 3rd month using the MIDAS and VAS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

1.6 years

First QC Date

March 5, 2022

Last Update Submit

March 24, 2024

Conditions

Keywords

Migrain, Wet Cupping, Acupuncture, VAS, MIDAS

Outcome Measures

Primary Outcomes (2)

  • The change from the baseline (at 0 month) MIDAS scores at 3th month

    The Migraine Disability Assessment (MIDAS) questionnaire is a brief, self-administered questionnaire designed to quantify headache-related disability over a 3 month period.

    At 0 and 3 months

  • The change from the baseline (at 0 month) VAS scores at 3 th month

    Visual analogue scales (VAS) are well-validated instruments for assessing pain intensity. Scores are recorded by a mark on a 10-cm line that represents 0 as "no pain" and 10 as "worst pain."

    At 0 and 3 months

Study Arms (3)

Wet cupping therapy

EXPERIMENTAL

The intervention group will undergo 3 successive wet cupping therapy (WCT) sessions once in a month throughout 3 months (On 0, 30, and 60 days. Cups will be held for 5 minutes on the 5 regions of the C7 cervical spine (DU14 acupuncture point), bilateral T2-4 lateral spine (BL41-42 acupoint) and bilateral T6-8 lateral spine (BL44-46) points, which are recommended areas for headache, Then, these areas where the blood supply has increased will be drawn with a sterile lancet and the cup will be applied again and left for 10 minutes, and then the cups will be removed and the accumulated blood will be cleaned.

Procedure: Wet cupping therapy

Acupuncture

EXPERIMENTAL

Acupuncture application will be done by manually needling selected acupuncture points specific to the disease twice a week for 4 weeks. After the needles are placed, they will be manipulated to create a feeling of de-qi and left for 20 minutes.

Procedure: Acupuncture

Control

NO INTERVENTION

Control group will not receive any intervention

Interventions

Wet cupping therapy is a bloodletting application done by cups on the skin

Also known as: Hijama
Wet cupping therapy
AcupuncturePROCEDURE

Acupuncture is a complementary application of TCM done by needles

Acupuncture

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between the ages of 18-65 who were diagnosed with migraine, no concomitant chronic disease and who gave their consent to participate in the study will be recruited.

You may not qualify if:

  • \. Having a bleeding diathesis
  • \. Receiving antithrombotic and antiaggregant therapy
  • \. Chronic disease that requires continuous drug use have
  • \. Wet cupping or hirudotherapy treatment in the last 3 months to have received 5.Be younger than 18 years old and over 65 years old 6. Having a hemoglobin value below 9.5 g/dl 7. INR value over 1.5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umraniye Training and Research Hospital

Istanbul, İ̇stanbul, 34070, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Migraine Disorders

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Emin Pala

    Saglik Bilimleri Universitesi

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the complementary medicine department

Study Record Dates

First Submitted

March 5, 2022

First Posted

March 16, 2022

Study Start

January 1, 2022

Primary Completion

August 5, 2023

Study Completion

December 30, 2023

Last Updated

March 26, 2024

Record last verified: 2024-03

Locations